Avesthagen

Avesthagen (Avestha Gengraine Technologies) is a biotechnology and bioinformatics company located in Bangalore, India, focusing on food, pharmaceuticals, and nutraceuticals.

Additional recommended knowledge

Daily Visual Balance Check

Don't let static charges disrupt your weighing accuracy

Daily Sensitivity Test

Avesthagen was founded in 1998 by Dr Villoo Morawala Patell, who remains Chief Executive Officer of the Company. It currently employs 215 people who focus on research with universities and pharmaceutical companies around the globe. This company has developed natural ingredients derived from plants, that are traditionally used in Indian medicine, and have been proven to be beneficial for conditions such as diabetes, obesity, and metabolic syndrome.

The company has successfully secured its first international patents and its subsidiary Avesthagen Quality Agriculture Services ("AQUAS") was an early leader in GMO testing in India.

Avesthagen opened a European office in Cambridge in 2004, securing deals that are said to have generated 35% of recent revenue.^[1]

Mr. Bruce Murdoch, Chief Business Officer joined Avesthagen in October 2006. A former head of schering plough in Indonesia.

Shareholders

Danone group (France), bioMérieux (France), Groupe Limagrain (France), Fidelity International (USA), New York Life Investment Management(USA), ICICI Ventures (India), Tata Industries (India), Godrej Industries Ltd(India), Cipla Ltd (India) and Bennett Coleman (India). ^[2]

Notes

1. ^ India Economic News by Indian Embassy, The Netherlands, June 2006 p.11 accessed at [1] Oct 2, 2006. Avesthagen was also visited by the UK Government Science & Technology Minister in 2006 [2]
2. ^